Tag:
Spinal Muscular Atrophy Foundation
Latest Headlines
Latest Headlines
Roche, PTC strike potential $490M deal for genetic disease program
Swiss drug giant Roche has bought exclusive rights to PTC Therapeutics ' program for spinal muscular atrophy (SMA) for $30 million upfront, providing PTC with another major pharma collaboration to
Hedge fund operator proffers $100M to find a drug for his daughter
Like other nonprofits, the Spinal Muscular Atrophy Foundation has provided a rich source of funds for drug developers working to treat a rare condition. PTC Therapeutics and Isis Pharmaceuticals have
